Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test.

Blood pressure Diabetes Hypertension Insulin resistance

Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 22 05 2023
accepted: 20 09 2023
medline: 6 10 2023
pubmed: 6 10 2023
entrez: 6 10 2023
Statut: aheadofprint

Résumé

It is known that, a not physiological blood pressure (BP) circadian pattern has been associated with increased risk of organ damage and cardiovascular (CV) event. The aim of this study was to assess the association between circadian BP pattern and glucometabolic phenotypes occurring after oral glucose tolerance test (OGTT). We recruited 810 hypertensive Caucasian patients. All participants underwent to OGTT, laboratory test and 24-h ambulatory BP monitoring (ABPM). The analysis of collected data allowed classifying patients based on nocturnal BP profiles into four categories: dippers, non-dippers, extreme dippers, and reverse dippers. Considering the dipping pattern, the proportion of non-dippers in normal glucose tolerance patients with 1-h glucose ≥ 155 mg/dL (NGT ≥ 155) (36.4%) was higher than NGT < 155 (29.6%) and impaired glucose tolerance (IGT) (34.8%), but lower than type 2 diabetes group (T2DM) (52.6%) (p = 0.001). The proportion of dippers was lower in NGT ≥ 155 (47%) and T2DM (34.6%), when compared with NGT < 155 (53.8%) and IGT (51.2%) (p = 0.017). From logistic regression analysis, 1-h glucose ≥ 155 increased the risk of a pathological nocturnal drop in BP by 74%, (OR = 1.740, 95% CI 1.254-2.415, p < 0.0001). In addition, the improvement in 1 unit of Matsuda was responsible for a 3.5% risk decrease (OR = 0.965, 95% CI 0.958-0.971, p < 0.0001), while e-GFR determined a 0.9% risk reduction of nocturnal BP drop (OR = 0.991, 95% CI 0.984-0.999, p = 0.020). Our data demonstrated the existence, in newly diagnosed hypertensive patients, of an association between circadian BP profile and altered glycemic response during OGTT, in particular NGT ≥ 155 subjects are associated with a non-dipper BP pattern, this is clinically relevant because may explain, at least in part, the increased CV risk in this setting of patients.

Identifiants

pubmed: 37801209
doi: 10.1007/s11739-023-03442-1
pii: 10.1007/s11739-023-03442-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Williams B, Mancia G, Spiering W et al (2018) 2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension ESC/ESH task force for the management of arterial hypertension. J Hypertens 36:2284–2309
doi: 10.1097/HJH.0000000000001961 pubmed: 30379783
Chow CK, Teo KK, Rangarajan S et al (2013) Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310:959–968. https://doi.org/10.1001/jama.2013.184182
doi: 10.1001/jama.2013.184182 pubmed: 24002282
Fabbian F, Smolensky MH, Tiseo R et al (2013) Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int 30:17–30. https://doi.org/10.3109/07420528.2012.715872
doi: 10.3109/07420528.2012.715872 pubmed: 23002916
Chadachan VM, Ye MT, Tay JC et al (2018) Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice. Int J Gen Med 11:241–254
doi: 10.2147/IJGM.S164903 pubmed: 29950885 pmcid: 6018855
Smolensky MH, Hermida RC, Portaluppi F (2017) Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev 33:4–16
doi: 10.1016/j.smrv.2016.02.003 pubmed: 27076261
Kario K, Hoshide S, Mizuno H et al (2020) Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study. Circulation 142:1810–1820. https://doi.org/10.1161/CIRCULATIONAHA.120.049730
doi: 10.1161/CIRCULATIONAHA.120.049730 pubmed: 33131317 pmcid: 7643792
Pelaia C, Armentaro G, Miceli S et al (2021) Association between sleep Apnea and Valvular heart diseases. Front Med. https://doi.org/10.3389/fmed.2021.667522
doi: 10.3389/fmed.2021.667522
Catalano F, De Vito F, Cassano V, Fiorentino TV, Sciacqua AHM (2022) Circadian clock desynchronization and insulin resistance. Int J Env Res Public Heal 20:29
doi: 10.3390/ijerph20010029
da Silva AA, do Carmo JM, Li X et al (2020) Role of HYPERINSULINEMIA AND INSULIN RESISTANCE IN HYPERTENSION: METABOLIC SYNDROME REVISited. Can J Cardiol 36:671–682
doi: 10.1016/j.cjca.2020.02.066 pubmed: 32389340
Tiwari S, Riazi S, Ecelbarger CA (2007) Insulin’s impact on renal sodium transport and blood pressure in health, obesity, and diabetes. Am J Physiol Ren Physiol 293:F974–84.
Lteif AA, Han K, Mather KJ (2005) Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112:32–38. https://doi.org/10.1161/CIRCULATIONAHA.104.520130
doi: 10.1161/CIRCULATIONAHA.104.520130 pubmed: 15983246
Cassano V, Tripepi G, Perticone M et al (2021) Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex. Hypertens Res 44:1451–1461. https://doi.org/10.1038/s41440-021-00716-z
doi: 10.1038/s41440-021-00716-z pubmed: 34471254
Abdul-Ghani MA, Ali N, Abdul-Ghani T, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655. https://doi.org/10.2337/dc08-0225
doi: 10.2337/dc08-0225 pubmed: 18487478 pmcid: 2494641
Cassano V, Miceli S, Armentaro G et al (2022) Oxidative stress and left ventricular performance in patients with different glycometabolic phenotypes. Nutrients. https://doi.org/10.3390/nu14061299
doi: 10.3390/nu14061299 pubmed: 35334956 pmcid: 8950717
Sciacqua A, Perticone M, Miceli S et al (2019) Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients. Endocrine 64:525–535. https://doi.org/10.1007/s12020-019-01873-5
doi: 10.1007/s12020-019-01873-5 pubmed: 30790176
Succurro E, Arturi F, Lugarà M et al (2010) One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 5:1922–1927. https://doi.org/10.2215/CJN.03240410
doi: 10.2215/CJN.03240410 pubmed: 20595688 pmcid: 3001771
Andreozzi F, Succurro E, Mancuso MR et al (2007) Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold. Diabetes Metab Res Rev 23:547–550. https://doi.org/10.1002/dmrr.724
doi: 10.1002/dmrr.724 pubmed: 17311284
Standards of Medical Care in Diabetes (2019) American Diabetes Association. 2. Classification and diagnosis of diabetes. Diab Care 42:S13–S28
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470. https://doi.org/10.2337/diacare.22.9.1462
doi: 10.2337/diacare.22.9.1462 pubmed: 10480510
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
doi: 10.7326/0003-4819-150-9-200905050-00006 pubmed: 19414839 pmcid: 2763564
Rowe JW, Young JB, Minaker KL et al (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219–225. https://doi.org/10.2337/diab.30.3.219
doi: 10.2337/diab.30.3.219 pubmed: 7009270
da Franco CC, S, Previate C, Trombini AB et al (2021) Metformin improves autonomic nervous system imbalance and metabolic dysfunction in monosodium L-Glutamate-treated rats. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2021.660793
doi: 10.3389/fendo.2021.660793 pubmed: 34566892 pmcid: 8212417
Nakano Y, Oshima T, Ozono R et al (2001) Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy. Auton Neurosci Basic Clin 88:181–186. https://doi.org/10.1016/S1566-0702(01)00238-7
doi: 10.1016/S1566-0702(01)00238-7
Kohara K, Nishida W, Maguchi M, Hiwada K (1995) Autonomic nervous function in non-dipper essential hypertensive subjects: evaluation by power spectral analysis of heart rate variability. Hypertension 26:808–814. https://doi.org/10.1161/01.HYP.26.5.808
doi: 10.1161/01.HYP.26.5.808 pubmed: 7591022
Diamantopoulos EJ, Andreadis E, Tsourous G et al (2006) Insulin resistance and blood pressure circadian variation in an obese hypertensive population. Clin Exp Hypertens 28:625–630. https://doi.org/10.1080/10641960600946106
doi: 10.1080/10641960600946106 pubmed: 17060061
Ayala DE, Moyá A, Crespo JJ et al (2013) Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int 30:99–115. https://doi.org/10.3109/07420528.2012.701489
doi: 10.3109/07420528.2012.701489 pubmed: 23098178
Sciacqua A, Miceli S, Carullo G et al (2011) One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34:1406–1411. https://doi.org/10.2337/dc11-0155
doi: 10.2337/dc11-0155 pubmed: 21515837 pmcid: 3114345
Sciacqua A, Miceli S, Greco L et al (2011) One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diab Care 34:2291–2296. https://doi.org/10.2337/dc11-0879
doi: 10.2337/dc11-0879
Sciacqua A, Maio R, Miceli S et al (2012) Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS ONE. https://doi.org/10.1371/journal.pone.0044470
doi: 10.1371/journal.pone.0044470 pubmed: 23028545 pmcid: 3441532
Succurro E, Marini MA, Arturi F et al (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:245–249. https://doi.org/10.1016/j.atherosclerosis.2009.04.006
doi: 10.1016/j.atherosclerosis.2009.04.006 pubmed: 19410252
Ivanovic BA, Tadic MV, Celic VP (2013) To dip or not to dip the unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens 27:62–70. https://doi.org/10.1038/jhh.2011.83
doi: 10.1038/jhh.2011.83 pubmed: 21900953
Komori T, Eguchi K, Saito T et al (2016) Riser blood pressure pattern is associated with mild cognitive impairment in heart failure patients. Am J Hypertens 29:194–201. https://doi.org/10.1093/ajh/hpv086
doi: 10.1093/ajh/hpv086 pubmed: 26066331
Pogue V, Rahman M, Lipkowitz M et al (2009) Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53:20–27. https://doi.org/10.1161/HYPERTENSIONAHA.108.115154
doi: 10.1161/HYPERTENSIONAHA.108.115154 pubmed: 19047584
Cha RH, Kim S, Yoon SA et al (2014) Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: Results of the APrODiTe study. Hypertens Res 37:172–178. https://doi.org/10.1038/hr.2013.127
doi: 10.1038/hr.2013.127 pubmed: 24048482
Marinakis AG, Vyssoulis GP, Michaelides AP et al (2003) Impact of abnormal nocturnal blood pressure fall on vascular function. Am J Hypertens 16:209–213. https://doi.org/10.1016/S0895-7061(02)03262-4
doi: 10.1016/S0895-7061(02)03262-4 pubmed: 12620699
García-Ortiz L, Gómez-Marcos MA, Martín-Moreiras J et al (2009) Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). Blood Press Monit 14:145–151. https://doi.org/10.1097/MBP.0b013e32832e062f
doi: 10.1097/MBP.0b013e32832e062f pubmed: 19581802
Yan B, Peng L, Han D et al (2015) Blood pressure reverse-dipping is associated with early formation of carotid plaque in senior hypertensive patients. Med (United States). https://doi.org/10.1097/MD.0000000000000604
doi: 10.1097/MD.0000000000000604 pmcid: 4924477
Minutolo R, Agarwal R, Borrelli S et al (2011) Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 171:1090–1098. https://doi.org/10.1001/archinternmed.2011.230
doi: 10.1001/archinternmed.2011.230 pubmed: 21709109
Kario K, Pickering TG, Matsuo T et al (2001) Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38:852–857. https://doi.org/10.1161/hy1001.092640
doi: 10.1161/hy1001.092640 pubmed: 11641298
Yamamoto Y, Akiguchi I, Oiwa K et al (2005) The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 19:302–308. https://doi.org/10.1159/000084498
doi: 10.1159/000084498 pubmed: 15775671
Yan B, Peng L, Dong Q et al (2015) Reverse-dipper pattern of blood pressure may predict lacunar infarction in patients with essential hypertension. Eur J Neurol. https://doi.org/10.1111/ene.12659
doi: 10.1111/ene.12659 pubmed: 26706832
Castilla-Guerra L, Espino-Montoro A, Fernández-Moreno MC, López-Chozas JM (2009) Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different? Int J Stroke 4:257–261. https://doi.org/10.1111/j.1747-4949.2009.00314.x
doi: 10.1111/j.1747-4949.2009.00314.x pubmed: 19689751
Yan B, Sun L, Gao Y et al (2016) Blood pressure reverse dipping may associate with stable coronary artery disease in patients with essential hypertension: a cross-sectional study. Sci Rep. https://doi.org/10.1038/srep25410
doi: 10.1038/srep25410 pubmed: 28008989 pmcid: 5180238
Komori T, Eguchi K, Saito T et al (2016) Riser pattern: another determinant of heart failure with preserved ejection fraction. J Clin Hypertens 18:994–999. https://doi.org/10.1111/jch.12818
doi: 10.1111/jch.12818
Cuspidi C, Sala C, Tadic M et al (2017) Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review. J Clin Hypertens 19:713–721
doi: 10.1111/jch.13023

Auteurs

Valentino Condoleo (V)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Raffaele Maio (R)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Velia Cassano (V)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy. velia.cassano@unicz.it.

Leonilde Bonfrate (L)

Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.

Corrado Pelaia (C)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Giuseppe Armentaro (G)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Sofia Miceli (S)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Teresa Vanessa Fiorentino (TV)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Maria Perticone (M)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.

Elena Succurro (E)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.
Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), University Magna Græcia, 88100, Catanzaro, Italy.

Francesco Andreozzi (F)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.
Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), University Magna Græcia, 88100, Catanzaro, Italy.

Giorgio Sesti (G)

Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Angela Sciacqua (A)

Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Campus Universitario "S. Venuta", Viale Europa-Località Germaneto, 88100, Catanzaro, Italy.
Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), University Magna Græcia, 88100, Catanzaro, Italy.

Classifications MeSH